Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

Two studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC), where information has previously been lacking despite being the age group most commonly affected. Immunotherapy with drugs that target immune pathways to enhance the body’s ability to recognise and destroy tumour cells is […]

Continue reading »

Standing in for a kidney, MXene materials could give dialysis patients the freedom to move

For more than 3 million people around the world, kidney failure is a life-altering diagnosis, if not a life-threatening one. While about 17 percent of people in the U.S. with end-stage kidney disease are now getting transplants, the average time spent waiting is 3-5 years. And much of that time is consumed by planning for, receiving and recovering from treatment. […]

Continue reading »